272 related articles for article (PubMed ID: 18339019)
1. Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.
Kikuchi E; Yamazaki K; Kikuchi J; Hasegawa N; Hashimoto S; Ishizaka A; Nishimura M
Respirology; 2008 Mar; 13(2):221-6. PubMed ID: 18339019
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
[TBL] [Abstract][Full Text] [Related]
3. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
Gotfried MH; Danziger LH; Rodvold KA
J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses.
Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
Pulm Pharmacol Ther; 2007; 20(5):549-55. PubMed ID: 17127087
[TBL] [Abstract][Full Text] [Related]
5. Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
Andrews J; Honeybourne D; Ashby J; Jevons G; Fraise A; Fry P; Warrington S; Hawser S; Wise R
J Antimicrob Chemother; 2007 Sep; 60(3):677-80. PubMed ID: 17623694
[TBL] [Abstract][Full Text] [Related]
6. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
Conte JE; Golden JA; McIver M; Zurlinden E
Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals.
Womble AY; Giguère S; Lee EA; Vickroy TW
Am J Vet Res; 2006 Oct; 67(10):1681-6. PubMed ID: 17014316
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
[TBL] [Abstract][Full Text] [Related]
9. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
Ikawa K; Kikuchi E; Kikuchi J; Nishimura M; Derendorf H; Morikawa N
J Clin Pharm Ther; 2014 Aug; 39(4):411-7. PubMed ID: 24661290
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
12. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
Conte JE; Golden JA; McIver M; Little E; Zurlinden E
Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
[TBL] [Abstract][Full Text] [Related]
13. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
Togami K; Chono S; Morimoto K
Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
[TBL] [Abstract][Full Text] [Related]
14. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.
Conte JE; Golden JA; Kelley MG; Zurlinden E
Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244
[TBL] [Abstract][Full Text] [Related]
15. Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid.
Yamazaki K; Ogura S; Ishizaka A; Oh-hara T; Nishimura M
Am J Respir Crit Care Med; 2003 Dec; 168(11):1304-7. PubMed ID: 12904323
[TBL] [Abstract][Full Text] [Related]
16. Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.
Zhang J; Xie X; Zhou X; Chen YQ; Yu JC; Cao GY; Wu XJ; Shi YG; Zhang YY
J Clin Pharmacol; 2010 Aug; 50(8):922-8. PubMed ID: 20035039
[TBL] [Abstract][Full Text] [Related]
17. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease.
Hasegawa N; Nishimura T; Watabnabe M; Tasaka S; Nakano Y; Yamazaki K; Hashimoto S; Nishimura M; Ishizaka A
Pulm Pharmacol Ther; 2009 Jun; 22(3):190-3. PubMed ID: 19061965
[TBL] [Abstract][Full Text] [Related]
19. Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects.
Chandorkar G; Huntington JA; Gotfried MH; Rodvold KA; Umeh O
J Antimicrob Chemother; 2012 Oct; 67(10):2463-9. PubMed ID: 22773741
[TBL] [Abstract][Full Text] [Related]
20. Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline.
Conte JE; Golden JA; Kelly MG; Zurlinden E
Int J Antimicrob Agents; 2005 Jun; 25(6):523-9. PubMed ID: 15885987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]